Medication Management

Watch DSN: Healthcare collaboration boosts outcomes for GLP-1 patients

Amanda Jochum, a registered dietitian with Hy-Vee, discusses GLP-1 medication side effects, patient support strategies and beneficial product recommendations.
NACDS to 118th Congress: Now, let’s get PBM reform done

NACDS President Steve Anderson said there remains an urgent need for the current 118th Congress to reform the tactics of market-dominant pharmaceutical middlemen.
Camber releases generic Xeloda

Capecitabine is a nucleoside metabolic inhibitor indicated for the treatment of several cancers.
Hims & Hers Health plans to launch generic of Novo Nordisk's Victoza

Liraglutide, used to treat Type 2 diabetes, belongs to the first generation of GLP-1 agonists.
FDA gives Lupin tentative nod for generic Isentress

Raltegravir tablets are indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus infection.
Alembic obtains FDA nod for generic Cardizem

Generic Cardizem is indicated for the treatment of hypertension and the management of chronic stable angina and angina due to coronary artery spasm.
Bora Pharmaceuticals acquires Pyros Pharmaceuticals

Pyros is a specialty pharmaceutical company developing treatments for rare diseases.
Sandoz launches generic paclitaxel in single-dose vial

The single-dose 100 mg vial for intravenous use is approved for metastatic breast cancer.

Drug shortages are down, report finds